Boothbay Fund Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $279,940 - $402,288	-16,783 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$14.8 - $21.15 $342,176 - $488,987	-23,120 Reduced 57.94%	16,783 $297,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $606,924 - $1.02 Million	39,903 New	39,903 $611,000
Q2 2020 Aug 14, 2020	SELL	$15.08 - $26.0 $791,081 - $1.36 Million	-52,459 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $93,049 - $167,149	8,459 Added 19.23%	52,459 $812,000
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $230,560 - $570,240	44,000 New	44,000 $487,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.